Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenues:    
Total revenues $ 7,353,266 $ 7,379,525
Cost of revenues 2,433,069 2,898,808
Research and development costs 2,310,139 2,813,733
Sales and marketing expenses 3,532,040 3,956,455
General and administrative expenses 4,325,786 4,046,366
Operating loss (5,247,768) (6,335,837)
Other income (expense):    
Gain on change in fair value of derivative liabilities 64,318 24,728
Other income, net 364 16,682
Interest expense, net (980,383) (872,926)
Net loss $ (6,163,469) $ (7,167,353)
Net loss per share attributable to common stockholders:    
Basic and diluted (in dollars per share) $ (0.56) $ (0.93)
Weighted average shares outstanding:    
Basic and diluted (in shares) 10,928,213 7,738,343
Product Revenue [Member]    
Revenues:    
Total revenues $ 6,685,020 $ 7,024,010
Service and Other Revenues [Member]    
Revenues:    
Total revenues $ 668,246 $ 355,515